Home » Topics » Regulatory » Patents

Patents
RSS

A novel series of immunosuppressants described in patent literature

Jan. 31, 2005

Kissei prepares and tests new agents for hyperuricemia

Jan. 31, 2005

New combinations comprising modafinil reported by Cephalon

Jan. 31, 2005

Lysophospholipid EDG receptor agonists disclosed in patents

Jan. 31, 2005

Small-particle suspensions of anticonvulsant, antidementia and immunosuppressive agents

Jan. 31, 2005

Pfizer team describes novel series of PPARalpha activators

Jan. 31, 2005

Novartis researchers claim PPAR modulators

Jan. 31, 2005

Merck presents new DPP-IV inhibitors with potential use in diabetes

Jan. 28, 2005

COX-2 inhibitors discovered by Merck team

Jan. 28, 2005

Merck reports novel prostaglandin D2 antagonists

Jan. 28, 2005

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...